These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

942 related items for PubMed ID: 14960742

  • 41. [Atrial natriuretic peptides: a new diagnostic tool for the internist].
    Boari B, Manfredini R, Fellin R.
    Recenti Prog Med; 2005 Jun; 96(6):300-10. PubMed ID: 16078761
    [Abstract] [Full Text] [Related]

  • 42. Usefulness of a combination of monocyte chemoattractant protein-1, galectin-3, and N-terminal probrain natriuretic peptide to predict cardiovascular events in patients with coronary artery disease.
    Tuñón J, Blanco-Colio L, Cristóbal C, Tarín N, Higueras J, Huelmos A, Alonso J, Egido J, Asensio D, Lorenzo Ó, Mahíllo-Fernández I, Rodríguez-Artalejo F, Farré J, Martín-Ventura JL, López-Bescós L.
    Am J Cardiol; 2014 Feb 01; 113(3):434-40. PubMed ID: 24295549
    [Abstract] [Full Text] [Related]

  • 43. [Predictive value of NT-pro-BNP for the non-cardiologist. A study on 573 hospitalized patients with cardiovascular disease].
    Pfister R, Tan D, Thekkanal J, Erdmann E, Schneider CA.
    Dtsch Med Wochenschr; 2008 Mar 01; 133(12):564-9. PubMed ID: 18335382
    [Abstract] [Full Text] [Related]

  • 44. Associations of plasma renin with 10-year cardiovascular mortality, sudden cardiac death, and death due to heart failure.
    Tomaschitz A, Pilz S, Ritz E, Morganti A, Grammer T, Amrein K, Boehm BO, März W.
    Eur Heart J; 2011 Nov 01; 32(21):2642-9. PubMed ID: 21606079
    [Abstract] [Full Text] [Related]

  • 45. Determinants of N-terminal proatrial natriuretic peptide plasma levels in a survey of adult male population from Southern Italy.
    Rubattu S, Barbato A, Marchitti S, Iacone R, Di Castro S, Evangelista A, Stanzione R, Ippolito R, Sciarretta S, Palmieri L, Volpe M, Strazzullo P, Olivetti Heart Study Research Group.
    J Hypertens; 2010 Aug 01; 28(8):1638-45. PubMed ID: 20453667
    [Abstract] [Full Text] [Related]

  • 46. Plasma natriuretic peptides and incidence of subtypes of ischemic stroke.
    Berntsson J, Zia E, Borné Y, Melander O, Hedblad B, Engström G.
    Cerebrovasc Dis; 2014 Aug 01; 37(6):444-50. PubMed ID: 25060145
    [Abstract] [Full Text] [Related]

  • 47. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes.
    Zethelius B, Berglund L, Sundström J, Ingelsson E, Basu S, Larsson A, Venge P, Arnlöv J.
    N Engl J Med; 2008 May 15; 358(20):2107-16. PubMed ID: 18480203
    [Abstract] [Full Text] [Related]

  • 48. Relation of soluble receptor for advanced glycation end products to predict mortality in patients with chronic heart failure independently of Seattle Heart Failure Score.
    Raposeiras-Roubín S, Rodiño-Janeiro BK, Grigorian-Shamagian L, Moure-González M, Seoane-Blanco A, Varela-Román A, Almenar-Bonet L, Alvarez E, González-Juanatey JR.
    Am J Cardiol; 2011 Mar 15; 107(6):938-44. PubMed ID: 21247530
    [Abstract] [Full Text] [Related]

  • 49. Serial measurement of growth-differentiation factor-15 in heart failure: relation to disease severity and prognosis in the Valsartan Heart Failure Trial.
    Anand IS, Kempf T, Rector TS, Tapken H, Allhoff T, Jantzen F, Kuskowski M, Cohn JN, Drexler H, Wollert KC.
    Circulation; 2010 Oct 05; 122(14):1387-95. PubMed ID: 20855664
    [Abstract] [Full Text] [Related]

  • 50. Plasma corin levels provide minimal prognostic utility incremental to natriuretic peptides in chronic systolic heart failure.
    Shrestha K, Troughton RW, Borowski AG, Yandle TG, Richards AM, Klein AL, Tang WH.
    J Card Fail; 2010 Aug 05; 16(8):621-7. PubMed ID: 20670840
    [Abstract] [Full Text] [Related]

  • 51. Prognostic significance of cardiovascular biomarkers and renal dysfunction in outpatients with systolic heart failure: a long term follow-up study.
    Bosselmann H, Egstrup M, Rossing K, Gustafsson I, Gustafsson F, Tonder N, Kistorp CN, Goetze JP, Schou M.
    Int J Cardiol; 2013 Dec 10; 170(2):202-7. PubMed ID: 24182673
    [Abstract] [Full Text] [Related]

  • 52. Changes in plasma natriuretic peptide levels in patients with atrial fibrillation after cardioversion.
    Wozakowska-Kaplon B.
    Int J Cardiol; 2010 Oct 29; 144(3):436-7. PubMed ID: 19556018
    [Abstract] [Full Text] [Related]

  • 53. Association of plasma natriuretic peptide levels with metabolic risk factors in ambulatory individuals.
    Wang TJ, Larson MG, Keyes MJ, Levy D, Benjamin EJ, Vasan RS.
    Circulation; 2007 Mar 20; 115(11):1345-53. PubMed ID: 17339551
    [Abstract] [Full Text] [Related]

  • 54. Comparative evaluation of B-type natriuretic peptide and mid-regional pro-A-type natriuretic peptide changes from admission to discharge in prognosis of acute decompensated heart failure patients.
    Stenner E, Buiatti A, Barbati G, Merlo M, Sinagra G, Biasioli B.
    Clin Lab; 2012 Mar 20; 58(5-6):585-9. PubMed ID: 22783593
    [Abstract] [Full Text] [Related]

  • 55. Cardiac risk scores in high-risk Hispanics and the predictive value of BNP.
    Macabasco-O'Connell A, Danwalder S, Sinha K.
    J Clin Nurs; 2011 Nov 20; 20(21-22):3039-46. PubMed ID: 21592244
    [Abstract] [Full Text] [Related]

  • 56. Mid-regional pro-atrial natriuretic peptide levels in the elderly: clinical and prognostic implications, and comparison to B-type natriuretic peptides.
    Eggers KM, Venge P, Lind L.
    Clin Chim Acta; 2013 Apr 18; 419():62-6. PubMed ID: 23415698
    [Abstract] [Full Text] [Related]

  • 57. Circulating endothelial progenitor cells and cardiovascular outcomes.
    Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Böhm M, Nickenig G.
    N Engl J Med; 2005 Sep 08; 353(10):999-1007. PubMed ID: 16148285
    [Abstract] [Full Text] [Related]

  • 58. N-terminal pro-B-type natriuretic peptide is an independent predictor of cardiovascular morbidity and mortality in the general population.
    Linssen GC, Bakker SJ, Voors AA, Gansevoort RT, Hillege HL, de Jong PE, van Veldhuisen DJ, Gans RO, de Zeeuw D.
    Eur Heart J; 2010 Jan 08; 31(1):120-7. PubMed ID: 19854731
    [Abstract] [Full Text] [Related]

  • 59. Predictive value of midregional pro-adrenomedullin compared to natriuretic peptides for incident cardiovascular disease and heart failure in the population-based FINRISK 1997 cohort.
    Funke-Kaiser A, Havulinna AS, Zeller T, Appelbaum S, Jousilahti P, Vartiainen E, Blankenberg S, Sydow K, Salomaa V.
    Ann Med; 2014 May 08; 46(3):155-62. PubMed ID: 24506434
    [Abstract] [Full Text] [Related]

  • 60. Plasma brain natriuretic peptide concentrations and the risk of cardiovascular events and death in general practice.
    Tsuchida K, Tanabe K.
    J Cardiol; 2008 Dec 08; 52(3):212-23. PubMed ID: 19027599
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 48.